Quantcast

Latest Comparative effectiveness research Stories

2014-08-18 12:27:06

Funding Announcement Includes Three New Topic Areas of Interest WASHINGTON, Aug. 18, 2014 /PRNewswire-USNewswire/ -- The Patient-Centered Outcomes Research Institute (PCORI) today issued the third funding announcement under its Pragmatic Clinical Studies initiative, offering up to $90 million in support for studies that address practical comparative questions faced by patients, clinicians, and other healthcare decision makers. PCORI will provide up to $10 million in direct costs for studies...

2014-08-13 12:28:35

Outcomes-Based Approaches by Payers May Support Value Messaging for Pharmaceuticals, According to Findings from Decision Resources Group BURLINGTON, Mass., Aug. 13, 2014 /PRNewswire/ -- Decision Resources Group finds that the outlook for the pharmaceutical market in the United States is becoming more favorable, as the size of the insured population is expanding and opportunities for specialty pharmaceutical products support premium pricing and better profitability. The implementation of the...

2014-07-29 23:15:48

Doctor Evidence, LLC has developed a comprehensive database of clinical evidence in Hepatitis C (HCV) to address the evolving needs of healthcare stakeholders. Santa Monica, CA (PRWEB) July 29, 2014 Doctor Evidence (“DRE”), the Santa Monica, California-based healthcare information leader has responded to marketplace clamor related to the transformative innovations in Hepatitis C virus (HCV) treatments with a comprehensive comparative effectiveness database that allows healthcare...

2014-07-29 16:25:54

33 Studies Explore Diverse Ways to Help Patients, Other Stakeholders Make Better-Informed Care Decisions WASHINGTON, July 29, 2014 /PRNewswire-USNewswire/ -- The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today approved $54.8 million in funding to support 33 new patient-centered comparative clinical effectiveness research (CER) projects that will study health conditions and concerns that affect millions of Americans. The approved proposals include...

2014-07-22 12:29:56

LEBANON, N.H., July 22, 2014 /PRNewswire-USNewswire/ -- John D. Birkmeyer, MD, an internationally recognized leader in outcomes research and quality improvement, has been named to the position of Executive Vice President for Enterprise Support Services across the Dartmouth-Hitchcock health system. In this newly-created position, he will work with CEO and President Dr. James N. Weinstein and key members of the senior management team to create a sustainable health system - a regional...

2014-07-02 16:25:01

BALTIMORE, July 2, 2014 /PRNewswire-USNewswire/ -- The Center for Medical Technology Policy (CMTP) has issued an Effectiveness Guidance Document (EGD) for Recommendations for Late Phase Drug Studies in Type 2 Diabetes. The EGD provides guidance for improving the design, conduct, and reporting of late phase (approval and post-approval) drug studies for patients with type 2 diabetes. The EGD includes specific recommendations for the design of prospective clinical studies that...

2014-06-30 16:26:25

--Messner, Houtsmuller to join executive team-- BALTIMORE, June 30, 2014 /PRNewswire-USNewswire/ -- CMTP today announced the promotion of Donna Messner, PhD, and Els Houtsmuller, PhD, who will both take on the roles of Vice President and Senior Research Director. "CMTP continues to find new opportunities to work with private, nonprofit and public partners to ensure that patients, clinicians, policymakers and payers have the evidence they need to make informed health decisions,"...

2014-06-23 12:28:23

BALTIMORE and BOSTON, June 23, 2014 /PRNewswire-USNewswire/ -- The Center for Medical Technology Policy's (CMTP) Green Park Collaborative (GPC) and the Institute for Clinical and Economic Review (ICER) will co-host a web conference to explore the evidence needed to demonstrate effectiveness and value of new drugs to treat chronic hepatitis C infection. The web conference will take place Monday, July 7, at 12:00 pm EDT. Recently approved medications for hepatitis C have been the focus of...

2014-06-17 12:28:38

Regenstrief Institute joins ConvergeHEALTH's consortium to support a rapid-learning network NEW YORK and INDIANAPOLIS, June 17, 2014 /PRNewswire/ -- ConvergeHEALTH by Deloitte and the Regenstrief Institute, Inc. are announcing that Regenstrief, an internationally recognized informatics and health care research organization, has become a member of ConvergeHEALTH's real-world evidence and analytics consortium. http://photos.prnewswire.com/prnvar/20120803/MM52028LOGO-a Regenstrief...

2014-06-09 12:31:11

BALTIMORE, June 9, 2014 /PRNewswire-USNewswire/ -- The Center for Medical Technology Policy (CMTP) welcomes Dr. Eleanor Perfetto, a Professor of Pharmaceutical Health Services Research, at the University of Maryland School of Pharmacy, to their Board of Directors. Dr. Perfetto joins Mark Gibson of the Center for Evidence-Based Policy, Peter Mazonson of ClearCost Health, Lawrence Sadwin, and CMTP CEO Sean Tunis as CMTP's current board members. "It's really now, more than ever, that...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related